STOCK TITAN

Amgen To Present At The Jefferies Virtual London Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Amgen (NASDAQ:AMGN) will present at the Jefferies Virtual London Healthcare Conference on November 18, 2020, at 12:00 p.m. ET. The presentation will be led by Peter H. Griffith, executive vice president and CFO of Amgen. Interested parties can access the live audio through the Events Calendar on Amgen's website, with a replay available for at least 90 days post-event. As a leader in biotechnology, Amgen is dedicated to discovering innovative therapies for serious illnesses, leveraging advanced human genetics to enhance health outcomes.

Positive
  • None.
Negative
  • None.

THOUSAND OAKS, Calif., Nov. 13, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Jefferies Virtual London Healthcare Conference at 12:00 p.m. ET on Wednesday, Nov. 18, 2020. Peter H. Griffith, executive vice president and chief financial officer at Amgen will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors. A replay of the webcast will also be available on Amgen's website for at least 90 days following the event.

About Amgen 
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.  

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.  

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.  

CONTACT: Amgen, Thousand Oaks 
Megan Fox, 805-447-1423 (media)
Trish Rowland, 805-447-5631(media) 
Arvind Sood, 805-447-1060 (investors) 

Amgen Logo. (PRNewsFoto/Amgen) (PRNewsFoto/)

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-jefferies-virtual-london-healthcare-conference-301172939.html

SOURCE Amgen

FAQ

When will Amgen present at the Jefferies Virtual London Healthcare Conference?

Amgen will present at the Jefferies Virtual London Healthcare Conference on November 18, 2020, at 12:00 p.m. ET.

Who will represent Amgen at the Jefferies Virtual London Healthcare Conference?

Peter H. Griffith, executive vice president and chief financial officer, will represent Amgen at the conference.

How can I listen to Amgen's presentation at the Jefferies Conference?

You can access the live audio of Amgen's presentation through the Events Calendar on their website.

Is there a replay available for Amgen's presentation?

Yes, a replay of the presentation will be available on Amgen's website for at least 90 days after the event.

What is Amgen's focus in biotechnology?

Amgen focuses on discovering and developing innovative therapies for serious illnesses, leveraging advanced human genetics.

Amgen Inc

NASDAQ:AMGN

AMGN Rankings

AMGN Latest News

AMGN Stock Data

150.64B
536.44M
0.25%
81.23%
1.74%
Drug Manufacturers - General
Biological Products, (no Disgnostic Substances)
Link
United States of America
THOUSAND OAKS